Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 20, 2021

SELL
$57.74 - $65.43 $227,380 - $257,663
-3,938 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $226,159 - $250,614
3,938 New
3,938 $237,000
Q4 2019

Jan 13, 2020

SELL
$49.21 - $64.19 $309,481 - $403,690
-6,289 Closed
0 $0
Q3 2019

Oct 18, 2019

BUY
$42.77 - $50.71 $268,980 - $318,915
6,289 New
6,289 $302,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tuttle Capital Management, LLC Portfolio

Follow Tuttle Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tuttle Capital Management, LLC with notifications on news.